We are live on ! Find out more
INBX icon

Inhibrx
INBX

86 hedge funds and large institutions have $137M invested in Inhibrx in 2024 Q2 according to their latest regulatory filings, with 86 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

66.65% more ownership

Funds ownership: 0% → 66.65% (+67%)

44% more call options, than puts

Call options by funds: $2.23M | Put options by funds: $1.54M

Holders
86
Holders Change
+86
Holders Change %
–
% of All Funds
1.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
86
Increased
–
Reduced
–
Closed
–
Calls
$2.23M
Puts
$1.54M
Net Calls
+$685K
Net Calls Change
+$685K

Top Buyers

Rank Fund Capital Flow
1
Viking Global Investors
Viking Global Investors
Connecticut
+$27.9M
2
PA
Perceptive Advisors
New York
+$16.6M
3
BlackRock
BlackRock
New York
+$10.7M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$7.47M
5
Walleye Capital
Walleye Capital
New York
+$7.42M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Viking Global Investors
1
Viking Global Investors
Connecticut
$25.3M +$27.9M +1,787,705 New
PA
2
Perceptive Advisors
New York
$15.1M +$16.6M +1,064,026 New
BlackRock
3
BlackRock
New York
$9.68M +$10.7M +683,075 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$6.77M +$7.47M +478,028 New
Walleye Capital
5
Walleye Capital
New York
$6.73M +$7.42M +474,999 New
SI
6
Sofinnova Investments
California
$6.57M +$7.24M +463,315 New
SC
7
Slotnik Capital
Texas
$4.84M +$5.34M +341,605 New
AAM
8
Alpine Associates Management
Florida
$4.34M +$4.78M +305,967 New
Millennium Management
9
Millennium Management
New York
$4.3M +$4.74M +303,196 New
TAL
10
TIG Advisors LLC
New York
$3.45M +$3.81M +243,650 New
Morgan Stanley
11
Morgan Stanley
New York
$3.34M +$3.69M +235,916 New
IC
12
Ikarian Capital
Texas
$3.26M +$3.59M +230,000 New
Geode Capital Management
13
Geode Capital Management
Massachusetts
$2.98M +$3.29M +210,317 New
CM
14
Caption Management
Oklahoma
$2.83M +$3.12M +199,998 New
Marshall Wace
15
Marshall Wace
United Kingdom
$2.8M +$3.09M +197,500 New
TCM
16
Tang Capital Management
California
$2.37M +$2.62M +167,500 New
KCM
17
Kennedy Capital Management
Missouri
$2.34M +$2.58M +164,971 New
ACH
18
ArrowMark Colorado Holdings
Colorado
$2.16M +$2.38M +152,159 New
State Street
19
State Street
Massachusetts
$2.11M +$2.32M +148,586 New
Qube Research & Technologies (QRT)
20
Qube Research & Technologies (QRT)
United Kingdom
$2M +$2.21M +141,400 New
PHS
21
PFM Health Sciences
California
$1.92M +$2.12M +135,546 New
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
$1.81M +$1.99M +127,500 New
MI
23
MMCAP International
Cayman Islands
$1.6M +$1.76M +112,858 New
CL
24
CSS LLC
Illinois
$1.57M +$1.73M +110,651 New
HighTower Advisors
25
HighTower Advisors
Illinois
$1.52M +$1.68M +107,500 New
1
2 3 4

INBX Hedge Fund Activity: Q2 2024 in Review

86 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Inhibrx (INBX) for Q2 2024, worth a combined $137M.

Buyers outnumbered sellers: 86 funds opened new INBX positions and 0 closed out — a net gain of 86 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Viking Global Investors, opening a new position worth an estimated $27.9M.

  • 86 institutional investors held Inhibrx (INBX) as of Q2 2024, up from 0 in Q1 2024.
  • Funds reported $137M of Inhibrx stock for Q2 2024.
  • 86 funds opened new Inhibrx positions in Q2 2024 and 0 closed out, a net change of +86 holders.
  • The largest Inhibrx buyer in Q2 2024 was Viking Global Investors, an estimated $27.9M added.

Based on aggregated 13F filings for Q2 2024.